BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 211 filers reported holding BLUEBIRD BIO INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,279,165 | -16.5% | 420,778 | -9.7% | 0.00% | – |
Q2 2023 | $1,532,524 | -7.3% | 465,813 | -10.4% | 0.00% | – |
Q1 2023 | $1,652,510 | -71.3% | 519,657 | -37.7% | 0.00% | -100.0% |
Q4 2022 | $5,767,737 | +92.6% | 833,488 | +76.3% | 0.00% | – |
Q3 2022 | $2,994,000 | +11.4% | 472,876 | -27.2% | 0.00% | – |
Q2 2022 | $2,687,000 | -64.8% | 649,266 | -58.7% | 0.00% | -100.0% |
Q1 2022 | $7,628,000 | +56.7% | 1,572,805 | +222.9% | 0.00% | 0.0% |
Q4 2021 | $4,867,000 | -13.5% | 487,080 | +65.4% | 0.00% | 0.0% |
Q3 2021 | $5,629,000 | -74.3% | 294,572 | -57.0% | 0.00% | -66.7% |
Q2 2021 | $21,899,000 | +81.0% | 684,780 | +70.7% | 0.00% | +50.0% |
Q1 2021 | $12,098,000 | -50.9% | 401,263 | -29.6% | 0.00% | -50.0% |
Q4 2020 | $24,655,000 | +97.7% | 569,813 | +146.5% | 0.00% | +100.0% |
Q3 2020 | $12,471,000 | +128.1% | 231,135 | +158.0% | 0.00% | +100.0% |
Q2 2020 | $5,468,000 | -61.7% | 89,585 | -71.2% | 0.00% | -75.0% |
Q1 2020 | $14,283,000 | +314.7% | 310,752 | +691.8% | 0.00% | +300.0% |
Q4 2019 | $3,444,000 | -13.8% | 39,247 | -9.9% | 0.00% | 0.0% |
Q3 2019 | $3,997,000 | -67.2% | 43,542 | -54.5% | 0.00% | -66.7% |
Q2 2019 | $12,176,000 | -63.2% | 95,720 | -54.5% | 0.00% | -66.7% |
Q1 2019 | $33,070,000 | +36.2% | 210,198 | -14.1% | 0.01% | +28.6% |
Q4 2018 | $24,287,000 | -39.8% | 244,827 | -11.4% | 0.01% | -30.0% |
Q3 2018 | $40,362,000 | -9.3% | 276,460 | -2.5% | 0.01% | -16.7% |
Q2 2018 | $44,508,000 | -31.8% | 283,575 | -25.8% | 0.01% | -33.3% |
Q1 2018 | $65,225,000 | +152.0% | 381,987 | +162.8% | 0.02% | +157.1% |
Q4 2017 | $25,884,000 | +70.6% | 145,331 | +31.6% | 0.01% | +40.0% |
Q3 2017 | $15,172,000 | +35.3% | 110,461 | +3.5% | 0.01% | +66.7% |
Q2 2017 | $11,210,000 | -21.7% | 106,716 | -32.2% | 0.00% | +50.0% |
Q1 2017 | $14,310,000 | -20.9% | 157,430 | -46.3% | 0.00% | -33.3% |
Q4 2016 | $18,102,000 | +425.5% | 293,368 | +477.2% | 0.00% | +200.0% |
Q3 2016 | $3,445,000 | +182.1% | 50,822 | +80.4% | 0.00% | – |
Q2 2016 | $1,221,000 | -60.9% | 28,177 | -61.6% | 0.00% | -100.0% |
Q1 2016 | $3,119,000 | -3.4% | 73,376 | +45.9% | 0.00% | 0.0% |
Q4 2015 | $3,230,000 | -6.2% | 50,291 | +24.9% | 0.00% | 0.0% |
Q3 2015 | $3,444,000 | -74.3% | 40,256 | -49.4% | 0.00% | -80.0% |
Q2 2015 | $13,389,000 | +328.7% | 79,520 | +207.5% | 0.01% | +400.0% |
Q1 2015 | $3,123,000 | -9.6% | 25,863 | -31.4% | 0.00% | 0.0% |
Q4 2014 | $3,456,000 | -7.1% | 37,683 | -63.7% | 0.00% | 0.0% |
Q3 2014 | $3,720,000 | +406.8% | 103,700 | +445.0% | 0.00% | – |
Q2 2014 | $734,000 | +39.0% | 19,027 | -18.0% | 0.00% | – |
Q1 2014 | $528,000 | +543.9% | 23,214 | +490.4% | 0.00% | – |
Q4 2013 | $82,000 | -76.4% | 3,932 | -69.5% | 0.00% | – |
Q3 2013 | $347,000 | – | 12,884 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |